CURIS, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
CURIS, INC. (CRIS) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$4.22 million for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-10-31.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2011-10-31
- CURIS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2011-09-30 was -$4.22M.
- CURIS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2011-06-30 was -$4.93M.
- CURIS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2010-09-30 was -$1.50M.
- CURIS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2010-06-30 was -$2.06M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month |
|---|---|---|---|
| 2011-09-30 | -$4.22M 10-Q · filed 2011-10-31 | -$9.15M derived: sum of 2 quarters · filed 2011-10-31 | -$15.94M 10-Q · filed 2011-10-31 |
| 2011-06-30 | -$4.93M 10-Q · filed 2011-08-04 | -$11.73M 10-Q · filed 2011-08-04 | |
| 2010-09-30 | -$1.50M 10-Q · filed 2011-10-31 | -$3.56M derived: sum of 2 quarters · filed 2011-10-31 | $1.20M 10-Q · filed 2011-10-31 |
| 2010-06-30 | -$2.06M 10-Q · filed 2011-08-04 | $2.71M 10-Q · filed 2011-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |